Edwards Lifesciences Corporation
EWLast close · Oct 16, 202686.60−1.50 (−1.70%)
Market cap$49.9B
Key indicators
Revenue6.5B+14.6% on a year earlier
3.7B
4.3B
4.4B
5.2B
5.4B
6.0B
5.4B
6.1B
6.5B
6.8B
7.4B
8.2B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 3.7B | 4.3B+16.8% | 4.4B+0.9% | 5.2B+19.3% | 5.4B+2.9% | 6.0B+11.6% | 5.4B−9.4% | 6.1B+11.5% | 6.5B+14.6% | 6.8B | 7.4B | 8.2B | |
| — | 16.8% | 0.9% | 19.3% | 2.9% | 11.6% | -9.4% | 11.5% | 14.6% | 11.6% | 9.6% | 10.5% | |
| $1.13 | $1.64+45.9% | $1.30−20.9% | $2.38+83.1% | $2.44+2.5% | $2.30−5.7% | $6.97+203.0% | $1.83−73.7% | $1.74−75.0% | $3.00 | $3.39 | $3.81 | |
| Profitability | ||||||||||||
| 74.8% | 74.4%−0.4 pt | 75.4%+1.0 pt | 76.1%+0.8 pt | 79.9%+3.8 pt | 77.0%−2.9 pt | 79.5%+2.4 pt | 78.0%−1.4 pt | 77.8%−1.0 pt | · | · | · | |
| 20.1% | 26.4%+6.3 pt | 20.5%−5.9 pt | 32.3%+11.8 pt | 32.5%+0.2 pt | 25.5%−6.9 pt | 25.3%−0.2 pt | 20.8%−4.5 pt | 22.3%−3.6 pt | · | · | · | |
| — | — | — | 28.7% | 28.3%−0.5 pt | 23.4%−4.9 pt | 76.7%+53.4 pt | 17.7%−59.1 pt | 15.4%−57.5 pt | · | · | · | |
| — | — | — | 25.8% | 26.2%+0.5 pt | 21.1%−5.1 pt | 41.8%+20.7 pt | 10.4%−31.4 pt | — | · | · | · | |
| Cash | ||||||||||||
| 688.1M | 925.0M+34.4% | 647.3M−30.0% | 1.4B+117.3% | 973.6M−30.8% | 642.8M−34.0% | 289.9M−54.9% | 1.3B+360.5% | 1.4B+143.9% | · | · | · | |
| 18.5% | 21.3%+2.8 pt | 14.8%−6.5 pt | 26.9%+12.1 pt | 18.1%−8.8 pt | 10.7%−7.4 pt | 5.3%−5.4 pt | 22.0%+16.7 pt | 22.0%+11.7 pt | · | · | · | |
| Balance sheet | ||||||||||||
| 0.19x | 0.14x−0.05x | 0.13x−0.01x | 0.10x−0.03x | 0.10x+0.00x | 0.09x−0.01x | 0.06x−0.03x | 0.06x−0.00x | 0.06x−0.00x | · | · | · | |
| 640.80M | 636.60M−0.7% | 631.90M−0.7% | 631.20M−0.1% | 624.20M−1.1% | 609.40M−2.4% | 599.30M−1.7% | 585.80M−2.3% | 577.60M−1.8% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period. EPS and share counts before a stock split are restated in today's share terms.